DeLorean Artificial Intelligence
VenSearch VerifiedAbout
DeLorean AI develops predictive medical artificial intelligence software for healthcare payers and providers. Their core product, MARTI, uses AI and machine learning to predict disease onset and progression across chronic conditions including renal disease, diabetes, cardiovascular disease, behavioral health, and respiratory disease. The company aims to reduce medical loss ratios, lower hospitalizations, and shift healthcare toward value-based, preventive care.
Details
VenSearch Verified
VenSearch Intelligence
Ideal Customer
- DeLorean AI's sweet spot is enterprise and mid-market healthcare organizations — specifically health plans (payers), at-risk provider groups, dialysis chains, nephrology practices, and skilled nursing facilities that manage large chronic disease populations.
- The company initially targeted insurance companies but pivoted toward providers, finding that clinicians — who can directly change medications, order tests, and schedule interventions — are the most impactful end users.
Key Differentiators
- DeLorean AI's primary differentiator is its claim to be the first medical AI in the world to be biologically validated by independent third-party organizations — with predictions confirmed accurate at a 95–99% confidence level by groups including UnitedHealthcare and Innovative Renal Care.
- Unlike traditional healthcare AI tools that primarily forecast retrospectively, MARTI delivers real-time, predictive next-best-action recommendations before patients seek care, before claims are submitted, and before major health events occur, achieving 85–87% AUC prediction accuracy.
Industries Served
- DeLorean AI is focused almost exclusively on healthcare, specifically serving healthcare payers (health insurance companies), at-risk providers, dialysis centers, nephrology practices, skilled nursing facilities, and life sciences organizations.
- Its MARTI platform is purpose-built for chronic illness management across renal, diabetes, cardiovascular, behavioral health, and respiratory disease verticals.
Service Coverage
- DeLorean AI operates primarily in the United States, where it has expanded nationwide across healthcare settings including dialysis centers, nephrology practices, skilled nursing facilities, and health insurance organizations.
- The platform has been deployed at 14 clients, including a Fortune 5 healthcare organization, with notable presence in dialysis networks spanning 27 states through its partnership with Innovative Renal Care's 240-clinic network.
Partnerships
- DeLorean AI's most significant named technology partnership is with SambaNova Systems, an AI hardware and software vendor, on which DeLorean's Medical Renal Model has been deployed for renal care use cases.
- WellStack served as DeLorean AI's data platform partner for shared clients for several years prior to the acquisition, effectively functioning as a deep integration partner before the two companies merged.
Company Size & Ownership
- DeLorean AI was founded in 2019 by Dr. Severence MacLaughlin and is a small company with approximately 16–25 employees, depending on the source.
- The company raised a total of approximately $10.5–$11.4 million across multiple rounds, including a $3 million seed round in February 2022 and a $7.55 million Series A in September 2023 led by Sopris Venture Capital.
Compliance & Certifications
- No publicly disclosed SOC 2, ISO 27001, FedRAMP, or HITRUST certifications have been found for DeLorean AI.
- Operating in healthcare with access to protected health information, the company is subject to HIPAA requirements and offers an on-premises deployment option that allows clients to maintain direct control over their data, infrastructure, and security policies.
Compiled from public sources by VenSearch · Last researched October 14, 2026
Offerings
6 offeringsBehavioral Health Care Module
A specialized care module focused on behavioral health conditions prediction and management. Savings statistics are listed as coming soon, and the module is designed to identify and manage behavioral health risks within patient populations.
Cardiac Care Module
A specialized care module focused on cardiovascular disease prediction and management. It delivers per-patient-per-year savings of $1,000 per cardiovascular disease patient by identifying members at risk and enabling proactive clinical intervention.
Diabetes Care Module
A specialized care module targeting diabetes and pre-diabetes prediction and management. It provides per-patient-per-year savings of $2,800 for diabetes patients and $500 for pre-diabetes patients by detecting and intervening in disease progression before patients reach high-cost states.
MARTI (Medical Artificial Real Time Intelligence)
MARTI is an AI platform that proactively identifies high-risk patients, performs dynamic risk stratification, predicts health status transitions, and generates personalized care recommendations before patients seek care, before claims are submitted, and before major health events occur. It delivers 85-87% prediction accuracy and is reported to reduce medical loss ratio by up to $100 per member per month. The platform has been biologically validated by multiple independent third-party labs and is deployed at 14 clients including a Fortune 5 healthcare organization.
Renal Care Module
A specialized care module focused on chronic kidney disease (CKD) and end-stage renal disease (ESRD) prediction and management. It delivers per-patient-per-year savings of $15,000 for ESRD patients and $1,200 for CKD patients by identifying and intervening in renal disease progression before it escalates.
Respiratory Care Module
A specialized care module focused on respiratory disease prediction and management, listed as coming in Q1 of 2024. It is part of DeLorean AI's suite of five chronic illness management modules delivered through the MARTI platform.
Considering DeLorean Artificial Intelligence?
Our team will work with you to determine if DeLorean Artificial Intelligence is the right fit for your organization. From research and assessment through procurement negotiation and ongoing vendor management — we handle the entire process at no cost to you.